ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

AKBA Akebia Therapeutics Inc

1.3303
0.0003 (0.02%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Akebia Therapeutics Inc AKBA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0003 0.02% 1.3303 08:10:40
始値 安値 高値 終値 前日終値
1.32 1.29 1.35 1.34 1.33
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0305:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
2024/3/2809:26PRNUSAkebia Receives FDA Approval of Vafseo® (vadadustat) Tablets..
2024/3/1505:15PRNUSAkebia Therapeutics Reports Fourth Quarter and Full Year..
2024/3/1206:05PRNUSAkebia Therapeutics to Report Fourth Quarter and Full Year..
2024/3/0207:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0206:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
2024/3/0108:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0108:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:32EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0106:28EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0106:27EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2808:19EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2808:14EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2808:11EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1322:00EDGAR2Form 8-K - Current report
2024/2/0306:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
2024/2/0206:52EDGAR2Form 144 - Report of proposed sale of securities
2024/1/3106:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/3022:05EDGAR2Form 8-K - Current report
2024/1/3022:00PRNUSAkebia Secures $55 Million Term Loan Financing
2024/1/1907:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0922:30PRNUSAkebia Therapeutics Announces Appointment of Nicholas Grund..
2024/1/0906:08EDGAR2Form 8-K - Current report
2024/1/0822:02EDGAR2Form 8-K - Current report
2024/1/0306:30PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
2023/12/2022:00PRNUSAkebia Therapeutics to Present at the 42nd Annual J.P...
2023/12/1906:07EDGAR2Form 8-K - Current report
2023/12/0206:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
2023/11/2207:07EDGAR2Form 8-K - Current report
2023/11/2022:00PRNUSAkebia Therapeutics to Present at Piper Sandler Healthcare..
2023/11/0821:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:33EDGAR2Form 8-K - Current report
2023/11/0821:30PRNUSAkebia Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0305:34EDGAR2Form 8-K - Current report
2023/11/0305:30PRNUSAkebia Therapeutics Announces Favorable Payment Term..
2023/11/0205:05PRNUSAkebia Therapeutics Reports Inducement Grants Under Nasdaq..
2023/10/3121:00PRNUSAkebia Therapeutics to Report Third Quarter 2023 Financial..
2023/10/2605:06EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock